Dual-Responsive Nanoplatform Shows Preclinical Promise Against Triple-Negative Breast Cancer
A dual-responsive lipid nanoparticle platform induced tumor regression and remodeled the immune microenvironment in a preclinical murine model of triple-negative ...

